Phase I clinical study of pertuzumab, a novel HER dimerization inhibitor, in patients with advanced cancer

David B. Agus, Michael S. Gordon, Charles Taylor, Ronald B. Natale, Beth Karlan, David S. Mendelson, Michael F. Press, David E. Allison, Mark X. Sliwkowski, Grade Lieberman, Stephen M. Kelsey, Gwen Fyfe

Research output: Contribution to journalArticlepeer-review

365 Scopus citations

Fingerprint

Dive into the research topics of 'Phase I clinical study of pertuzumab, a novel HER dimerization inhibitor, in patients with advanced cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences